These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26062489)

  • 1. Start-ups fight for a place in Boston's biotech hub.
    Ledford H
    Nature; 2015 Jun; 522(7555):138-9. PubMed ID: 26062489
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotech patenting slows in 2004.
    Lawrence S
    Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
    [No Abstract]   [Full Text] [Related]  

  • 3. Biotech slumps in Q1.
    Lawrence S
    Nat Biotechnol; 2008 May; 26(5):486. PubMed ID: 18464769
    [No Abstract]   [Full Text] [Related]  

  • 4. Biotech blockbusters consolidate markets.
    Lawrence S
    Nat Biotechnol; 2006 Dec; 24(12):1466. PubMed ID: 17160033
    [No Abstract]   [Full Text] [Related]  

  • 5. The biotech drug market.
    Lawrence S
    Nat Biotechnol; 2004 Dec; 22(12):1496. PubMed ID: 15583645
    [No Abstract]   [Full Text] [Related]  

  • 6. Biotech hirings and firings.
    Francisco M
    Nat Biotechnol; 2009 Apr; 27(4):395. PubMed ID: 19352375
    [No Abstract]   [Full Text] [Related]  

  • 7. Biotech R&D goes further afield.
    Lawrence S
    Nat Biotechnol; 2006 Sep; 24(9):1052. PubMed ID: 16964201
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotech drug market steadily expands.
    Lawrence S
    Nat Biotechnol; 2005 Dec; 23(12):1466. PubMed ID: 16333279
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotech as an employer.
    Lawrence S
    Nat Biotechnol; 2007 Jan; 25(1):12. PubMed ID: 17211380
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotech on the rise: diabetes.
    Leewe J
    Biotechnol J; 2009 Feb; 4(2):172-3. PubMed ID: 19226551
    [No Abstract]   [Full Text] [Related]  

  • 11. Does biotech M&A benefit investors?
    Jacobs T
    Nat Biotechnol; 2004 Sep; 22(9):1085. PubMed ID: 15340472
    [No Abstract]   [Full Text] [Related]  

  • 12. Public biotech 2009-the numbers.
    Huggett B; Hodgson J; Lähteenmäki R
    Nat Biotechnol; 2010 Aug; 28(8):793-9. PubMed ID: 20697401
    [No Abstract]   [Full Text] [Related]  

  • 13. Pipelines turn to biotech.
    Lawrence S
    Nat Biotechnol; 2007 Dec; 25(12):1342. PubMed ID: 18066015
    [No Abstract]   [Full Text] [Related]  

  • 14. First-quarter biotech job picture.
    Francisco M
    Nat Biotechnol; 2013 May; 31(5):465. PubMed ID: 23657398
    [No Abstract]   [Full Text] [Related]  

  • 15. An interdisciplinary shift in demand for talent within the biotech industry.
    Nugent KL; Kulkarni A
    Nat Biotechnol; 2013 Sep; 31(9):853-5. PubMed ID: 24022161
    [No Abstract]   [Full Text] [Related]  

  • 16. Biotech on pace for record year.
    Yang W
    Nat Biotechnol; 2011 Sep; 29(9):780. PubMed ID: 21904312
    [No Abstract]   [Full Text] [Related]  

  • 17. Patent holdings of US biotherapeutic companies in major markets.
    Sebastian TE; Yerram CB; Saberwal G
    Drug Discov Today; 2009 May; 14(9-10):442-5. PubMed ID: 19429502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparedness in America's prime danger zone and at the Boston Marathon bombing site.
    Cole LA; Scott SR; Feravolo M; Lamba S
    Am J Disaster Med; 2014; 9(1):17-24. PubMed ID: 24715641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent drop reveals pressures on industry.
    Lawrence S
    Nat Biotechnol; 2004 Aug; 22(8):930-1. PubMed ID: 15286630
    [No Abstract]   [Full Text] [Related]  

  • 20. The origins of new drugs.
    Kneller R
    Nat Biotechnol; 2005 May; 23(5):529-30. PubMed ID: 15877061
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.